200 related articles for article (PubMed ID: 16223889)
1. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
[TBL] [Abstract][Full Text] [Related]
2. The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.
Atahan K; Küpeli H; Gür S; Yiğitbaşı T; Baskın Y; Yiğit S; Deniz M; Cökmez A; Tarcan E
Int J Med Sci; 2011 Feb; 8(2):148-55. PubMed ID: 21326957
[TBL] [Abstract][Full Text] [Related]
3. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
[TBL] [Abstract][Full Text] [Related]
4. Detection and identification of potential biomarkers of breast cancer.
Fan Y; Wang J; Yang Y; Liu Q; Fan Y; Yu J; Zheng S; Li M; Wang J
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1243-54. PubMed ID: 20237941
[TBL] [Abstract][Full Text] [Related]
5. Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors.
Habermann JK; Roblick UJ; Luke BT; Prieto DA; Finlay WJ; Podust VN; Roman JM; Oevermann E; Schiedeck T; Homann N; Duchrow M; Conrads TP; Veenstra TD; Burt SK; Bruch HP; Auer G; Ried T
Gastroenterology; 2006 Oct; 131(4):1020-9; quiz 1284. PubMed ID: 17030172
[TBL] [Abstract][Full Text] [Related]
6. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
[TBL] [Abstract][Full Text] [Related]
7. Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.
Belluco C; Petricoin EF; Mammano E; Facchiano F; Ross-Rucker S; Nitti D; Di Maggio C; Liu C; Lise M; Liotta LA; Whiteley G
Ann Surg Oncol; 2007 Sep; 14(9):2470-6. PubMed ID: 17594124
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarkers for detection of breast cancers: A prospective study.
Mathelin C; Cromer A; Wendling C; Tomasetto C; Rio MC
Breast Cancer Res Treat; 2006 Mar; 96(1):83-90. PubMed ID: 16322896
[TBL] [Abstract][Full Text] [Related]
9. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
[TBL] [Abstract][Full Text] [Related]
10. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.
Opstal-van Winden AW; Krop EJ; Kåredal MH; Gast MC; Lindh CH; Jeppsson MC; Jönsson BA; Grobbee DE; Peeters PH; Beijnen JH; van Gils CH; Vermeulen RC
BMC Cancer; 2011 Aug; 11():381. PubMed ID: 21871081
[TBL] [Abstract][Full Text] [Related]
11. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
[TBL] [Abstract][Full Text] [Related]
13. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
14. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
Kadowaki M; Sangai T; Nagashima T; Sakakibara M; Yoshitomi H; Takano S; Sogawa K; Umemura H; Fushimi K; Nakatani Y; Nomura F; Miyazaki M
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1105-15. PubMed ID: 21253761
[TBL] [Abstract][Full Text] [Related]
15. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
16. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
17. Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
Song J; Patel M; Rosenzweig CN; Chan-Li Y; Sokoll LJ; Fung ET; Choi-Miura NH; Goggins M; Chan DW; Zhang Z
Clin Chem; 2006 Jun; 52(6):1045-53. PubMed ID: 16574760
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
19. Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease.
Marks JR; Anderson KS; Engstrom P; Godwin AK; Esserman LJ; Longton G; Iversen ES; Mathew A; Patriotis C; Pepe MS
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):435-41. PubMed ID: 25471344
[TBL] [Abstract][Full Text] [Related]
20. Serum protein signature may improve detection of ductal carcinoma in situ of the breast.
Solassol J; Rouanet P; Lamy PJ; Allal C; Favre G; Maudelonde T; Mangé A
Oncogene; 2010 Jan; 29(4):550-60. PubMed ID: 19855429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
